Business organizations may be able to improve their Sustainability Performance (SP) by adopting Total Quality Management (TQM) concepts combined with Industry 4.0 (I4.0) technologies. This research has developed a model to investigate the influence of TQM and I4.0 on SP. It also analyzes the mediating role of TQM in the relationship between I4.0 and SP. A survey was conducted among 240 respondents employed in ready-made garment (RMG) industries in Bangladesh. A Structural Equation Modelling (SEM) technique was used to analyze the collected data. Research findings show that both TQM and I4.0 technologies have a significant impact on the sustainable growth of the Bangladeshi RMG sector. Moreover, it is observed that TQM mediates the relationship between I4.0 and SP. The findings show that TQM helps to explain the relationship between I4.0 and sustainable performance. This study will provide a guideline for industrial executives on securing sustainability through the adoption of TQM concepts and I4.0 technologies. We are not aware of any additional studies that look at the possible link between TQM, I4.0, and SP, as well as the mediating role of TQM between I4.0 and SP.

No abstract

Tunnelled central venous access devices (CVADs) are defined as any intravenous multipurpose catheters placed within the central veins for use in haemodialysis and administration of blood products or chemotherapy in oncology and haematological conditions. Frequent complications include thrombosis and catheter-related infection, which may lead to significant adverse patient outcomes. Once thrombosis is suspected correction should be attempted empirically with thrombolytic agents. Commonly available thrombolytic agents in the UK include urokinase (Syner-Kinase) and alteplase (Cathflo). It is well recognised that urokinase usage differs widely and concerns were raised by clinicians about the variation of dose regimens nationally. The objective of the CVAD Focus Group was to address this issue and offer guidance in the management of suspected thrombosis of CVAD with urokinase using two algorithms for renal and non-renal dysfunctional CVAD and to audit prospectively the outcomes of intervention.

No abstract

No abstract